ARDS (ARDS) Stock Price & Analysis
ARDS (ARDS) rose 0.00% to USD 0 as of September 8, 2026 at 09:36 UTC, according to Nexqual real-time market data.
ARDS last closed at USD 0; the session ranged USD 0–0 on volume of 10 shares. Market capitalization is —, with a 52-week range of USD 0–0.05 (PNK). Source: Nexqual, September 8, 2026 at 09:36 UTC.
Key Statistics (as of September 8, 2026 at 09:36 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.05 |
| Volume | 10 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (ARDS)
Nexqual's technical model rates ARDS "STRONG SELL" based on 1 bullish and 5 bearish signals across 129 daily candles, as of September 8, 2026 at 09:36 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATXI | Avenue Therapeutics, Inc. | USD 0.54 | ▼ 4.56% |
| EVLO | Evelo Biosciences, Inc. | USD 0 | ▲ 0% |
| KRBPQ | Kiromic BioPharma, Inc. | USD 0 | ▲ 0% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
| BCDA | BioCardia, Inc. | USD 1.08 | ▼ 2.7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:36 UTC. This page is informational and not investment advice.